About Kesar Pharma Limited
Data last updated:
Kesar Pharma Limited is a public limited company based in Gandhinagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2011PLC067520. Its GSTIN is 24AAECK5207A2Z6 (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6.9 Cr and a paid-up capital of ₹4.32 Cr. It was formerly known as Kesar Swasthya Private Limited. It is led by directors including Parth Hemant Parikh and Kevin Atul Vasani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot Survey No. 50 – P2 At Village Bileshwarpura Po. Chhatral Ta. Kalol, Gandhinagar, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.63 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹21.49 Lakh (net margin 1%) and EBITDA of ₹1.82 Cr (EBITDA margin 8.8%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 9% over five years.
The company has about 47 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Kesar Pharma. As per MCA filings, the company has open charges of ₹10.58 Cr and satisfied charges of ₹14.65 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 3 deals on record (1 rights issue, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹7 Cr; the latest was in August 2016. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Celsius Healthcare Private Limited. The company has 3 MSME Form 1 returns on record between 2019 and 2021, listing 164 overdue payments to 33 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kesarpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot Survey No. 50 – P2 At Village Bileshwarpura Po. Chhatral Ta. Kalol, Gandhinagar, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kesar Pharma Limited
The main business activity of Kesar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kesar Pharma Limited FY 2025 filings available
Kesar Pharma Limited reported revenue of ₹20.63 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kesar Pharma Limited
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 26% fall in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kesar Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.82 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹21.49 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kesar Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kesar Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kesar Pharma Limited
Kesar Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Celsius Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Aster Medipharm Private Limited | •••• | •••• | •••• | •••• | - | Jaipur, Rajasthan, India |
| Snehal Pharma & Surgicals Private Limited | •••• | •••• | •••• | •••• | 29 | Mumbai, Maharashtra, India |
| Sheetal Chemicals Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Instant Remedies Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Kesar Pharma Limited this company | •••• | •••• | •••• | •••• | - | Gandhinagar, Gujarat, India |
| Dewcare Concept Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Bda Health Care Private Limited | •••• | •••• | •••• | •••• | 74 | Parshivani, Maharashtra, India |
| Citro Pharma Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Medizest Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Verna, Goa, India |
| Morvin India Health Care Private Limited | •••• | •••• | •••• | •••• | 154 | Sanand, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Kesar Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Kesar Pharma Limited
Kesar Pharma Limited is audited by PIYUSH J. SHAH & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PIYUSH J. SHAH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kesar Pharma Limited
Kesar Pharma has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parth Hemant Parikh | Director | 06 Sep 2019 | 7 Years 1 Months | Current |
| Kevin Atul Vasani Also directs: Quantum Quench Health Private Limited | Director | 15 Apr 2025 | 1 Years 5 Months | Current |
| Prakash Ambalal Patel Also directs: Dhwanit Consultancy LLP, Kesar Finechem Private Limited, Hapax Pharma Private Limited and 2 more | Director | 18 Oct 2011 | 14 Years 11 Months | Current |
| Kalpesh Navnitlal Shah Also directs: Kesar Finechem Private Limited, Hapax Pharma Private Limited | Director | 01 May 2014 | 12 Years 5 Months | Current |
| Rumit Bharatbhai Gopani | Director | 15 Apr 2025 | 1 Years 5 Months | Current |
Ownership and Shareholding of Kesar Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kesar Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2025 | Hdb Financial Services Limited | ₹6.06 Cr | Open |
| 05 Feb 2024 | Sidbi | ₹1.4 Cr | Open |
| 28 Mar 2023 | Sidbi | ₹62.76 Lakh | Open |
| 06 Feb 2021 | Others | ₹55 Lakh | Open |
| 07 Sep 2020 | Others | ₹1.44 Cr | Open |
Total charge records: 11 View all charges
Deals & Funding of Kesar Pharma Limited
Kesar Pharma Limited has 3 deals on record (1 rights issue, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹7 Cr; the latest was in August 2016.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Rights issue | ₹1.41 Cr | Investors: 4 individuals |
| Mar 2012 | Funding round | ₹2 Cr | Investors: 4 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Kesar Pharma Limited
Kesar Pharma Limited has 1 court case on record: 1 filed by Kesar Pharma. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Kesar Pharma Limited
Kesar Pharma Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 164 overdue payments to 33 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 33)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Allpharma Care Private Limited | •••• | •••• | •••• |
| Asian Flavours & Fragrances | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| S K Packaging | •••• | •••• | •••• |
| Rakesh Chemicals (Chhatral) | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Kesar Pharma Limited
Kesar Pharma operates one associated brand: Kesar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical finished formulations including tablets and capsules are manufactured. | kesarpharma.com |
Employees and EPFO Compliance at Kesar Pharma Limited
Kesar Pharma Limited has a workforce of 47 employees as of Feb 24, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Kesar Pharma Limited
Kesar Pharma has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Kesar Finechem Private Limited | U24230GJ2021PTC127102 | Locked |
Showing major subsidiaries. Total: 1.
CIN History of Kesar Pharma Limited
Kesar Pharma has one previous CIN (Corporate Identification Number): U24239GJ2011PTC067520. The current CIN is U24239GJ2011PLC067520, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239GJ2011PLC067520 | Current |
| U24239GJ2011PTC067520 | Previous |
Recent Activity on Kesar Pharma Limited
Kesar Pharma Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Kevin Atul Vasani ceased to be Additional Director on 07 May 2025.
26 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kesar Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kesar Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kesar Pharma Limited
Kesar Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECK5207A2Z6 | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kesar Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kesar Pharma Limited
Kesar Pharma is an active public limited company based in Gandhinagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 October 2011 (15+ years old) and is registered under CIN U24239GJ2011PLC067520.
Kesar Pharma reported revenue of ₹20.63 Cr for FY 2025 (down 26% YoY).
Kesar Pharma has 5 current directors:
- Parth Hemant Parikh - Director
- Kevin Atul Vasani - Director
- Prakash Ambalal Patel - Director
- Kalpesh Navnitlal Shah - Director
- Rumit Bharatbhai Gopani - Director
Kesar Pharma reported a net profit of ₹21.49 Lakh (net margin 1%) and EBITDA of ₹1.82 Cr (EBITDA margin 8.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kesar Pharma is -25% over three years and -9% over five years. In the latest year (FY 2025) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kesar Pharma is 24AAECK5207A2Z6, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Kesar Pharma is U24239GJ2011PLC067520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kesar Pharma has 1 court case on record: 1 filed by the company.
Kesar Pharma was incorporated on 18 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kesar Pharma has 3 deals on record (1 rights issue, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹7 Cr; the latest was in August 2016.
The peers of Kesar Pharma by revenue are Celsius Healthcare Private Limited, Aster Medipharm Private Limited, Snehal Pharma & Surgicals Private Limited, Sheetal Chemicals Private Limited, Instant Remedies Private Limited and 5 more, all in the Pharma industry (Formulations).
Kevin Atul Vasani ceased to be Additional Director on 07 May 2025. Rumit Bharatbhai Gopani ceased to be Additional Director on 07 May 2025. Kevin Atul Vasani was appointed as Director on 15 Apr 2025. Kesar Pharma has 15 board changes on record in total.